Resources Contact Us Home
Browse by: INVENTOR PATENT HOLDER PATENT NUMBER DATE
 
 
Inventor:
Nakano; Hirofumi
Address:
Machida, JP
No. of patents:
17
Patents:












Patent Number Title Of Patent Date Issued
5925641 Farnesyltransferase inhibitor July 20, 1999
The present invention relates to a farnesyltransferase inhibitor and an antitumor agent comprising, as an active ingredient, a piperazinedione derivative represented by formula (I): ##STR1## wherein R.sup.1 and R.sup.2 independently represent lower alkyl, lower alkoxyalkyl, subst
5728830 Farnesyltransferase inhibitor March 17, 1998
The present invention relates to a farnesyltransferase inhibitor and an antitumor agent comprising, as an active ingredient, a piperazinedione derivative represented by formula (I): ##STR1## wherein R.sup.1 and R.sup.2 independently represent lower alkyl, lower alkoxyalkyl, subst
5717110 UCH15 compounds February 10, 1998
This invention relates to UCH15 compounds of the formula (I): ##STR1## wherein R.sup.1 represents a hydrogen atom or a hydroxyl group.
5686606 UCF116 compounds November 11, 1997
The present invention relates to UCF116 compounds represented by the formula (I) : ##STR1## wherein an example of Q.sup.1 representation is ##STR2## and an example of Q.sup.2 representation is ##STR3## which have antibacterial and antitumor activity and are useful as
5656736 Compound UCH9 August 12, 1997
The present invention relates to the compound UCH9 represented by the following formula: ##STR1## which has antibacterial and anti-tumor activity, and pharmaceutically acceptable salts thereof.
5565489 Epoxycyclohexenedione derivatives October 15, 1996
The present invention relates to an epoxycyclohexenedione derivative represented by formula (I): ##STR1## wherein R is a straight-chain or branched alkanoyl group having 10 to 25 carbon atoms, a straight-chain alkenoyl group having 10 to 25 carbon atoms, or a group represented by
5536850 Substance DC114-A1 July 16, 1996
The present invention relates to a novel substance DC114-A1 represented by the following formula (I): ##STR1##
5510501 Saintopin derivatives April 23, 1996
The present invention relates to Saintopin derivatives represented by the following formula (I): ##STR1## wherein R.sup.1 is hydrogen and R.sup.2 is SO.sub.2 OH (UCE 1022), or R.sup.1 is acetyl and R.sup.2 is H (Saintopin E), which are useful as antibacterial and anti-tumor agent
5079376 Novel substance UCT-1003 and process for producing the same January 7, 1992
Disclosed is novel compound UCT-1003 represented by the following formula: ##STR1## and having anti-tumor activity. UCT-1003 is produced by culturing a microorganism belonging to the genus Paecilomyces.
5066817 DC115A compounds produced by streptomyces sp. November 19, 1991
Disclosed are DC115A compounds represented by the following general formula: ##STR1## wherein R represents ethyl, propyl or 1-propenyl, and which have antibacterial and anti-tumor activity. DC115A compounds are produced by culturing a microorganism belonging to the genus Streptom
4999196 Compound DC-107 produced by Streptomyces sp. March 12, 1991
A novel compound, DC-107, is produced by culturing a microorganism belonging to the genus Streptomyces. It is useful as a medicine because of its antibacterial and anti-tumor activity.
4992570 UCN-1028A and UCN-1028C and process for the production thereof February 12, 1991
UCN-1028A and UCN-1028C having an anti-tumor activity and a protein kinase C inhibitory activity are produced by culturing a microorganism belonging to the genus Cladosporium.
4935415 UCN-01 and process for production thereof June 19, 1990
UCN-01 having an anti-tumor activity and an anti-bacterial activity is produced by culturing a microorganism belonging to the genus Streptomyces.
4914198 Novel substance UCY1003 and process for preparing the same April 3, 1990
Novel substance UCY1003 produced by culturing of a microorganism has the following chemical structure and analgesic, hypotensive and antifungal activities: ##STR1##
4847387 Antibiotic compounds DC-92B and DC-92D July 11, 1989
The present invention relates to novel compounds DC-92B and DC-92D having anthraquinone moiety and represented by the following planar structural formula (I) and to a process for producing the same. These compounds can be produced by culture of a microorganism belonging to the genus
4438197 Compound DC-38-V and process for production thereof March 20, 1984
The antibacterial compound DC-38-V is produced by culturing a microorganism belonging to the genus Streptomyces.
4340725 Novel compound DC-38-V and process for production thereof July 20, 1982
The antibacterial compound DC-38-V is produced by culturing a microorganism belonging to the genus Streptomyces.










 
 
  Recently Added Patents
Systems and methods for sensing external magnetic fields in implantable medical devices
Supporting multiple channels of a single interface
Image processing apparatus, image processing system, and image processing method
Pyrrolidine-1,2-dicarboxamide derivatives
Cryptography on a simplified elliptical curve
Non-visual presentation of information on an electronic wireless device
System for determining movement properties of a guided vehicle
  Randomly Featured Patents
Self-regulating air ventilation apparatus
Method for driving a liquid crystal display
Portable information processor and information processing method
Method producing slag ballast
Method for controlled hydrogen charging of metals
Window room air conditioner
Use of bioaugmentation and a controlled release nitrate source to reduce hydrogen sulfide concentrations in wastewater systems
Spirit level
Video processing device
Method of manufacturing a hemisphere shoe for a swash plate compressor